A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes

Journal of Experimental Medicine

Volumn 187, Issue 3, 1998, Pages 277-288

  Shichijo, Shigeki ^a   Nakao, Masanobu ^b   Imai, Yasuhisa ^a   Takasu, Hideo ^a   Kawamoto, Mayumi ^a   Niiya, Fumihiko ^a   Yang, Damu ^b   Toh, Yuji ^a   Yamana, Hideaki ^a   Itoh, Kyogo ^a,b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ARTICLE; CANCER PATIENT; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; GENE DELETION; GENE EXPRESSION; GENETIC CODE; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOTHERAPY; MOLECULAR CLONING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA ANTIGENS; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II; LEUCINE ZIPPERS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PEPTIDES; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032472799     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.3.277     Document Type: Article

References (38)

1. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1643-1647.
2. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, L. Rivoltini, S.L. Topalian, T. Miki, and S.A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA. 91:3515-3519.
3. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, K. Sakaguchi, E. Appella, J.R. Yannelli, G.J. Adema, T. Miki, and S.A. Rosenberg. 1994. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA. 91:6458-6462.
4. Brichard, V., A. Van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Lethé, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489-495.
5. Robbins, P.F., M. El-Gamil, Y.F. Li, Y. Kawakami, D. Loftus, E. Appella, and S.A. Rosenberg. 1996. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183:1185-1192.
6. Guilloux, Y., S. Lucas, V.G. Brichard, A. Van Pel, C. Viret, E. De Plaen, F. Brasseur, B. Lethé, F. Jotereau, and T. Boon. 1996. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanoma is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J. Exp. Med. 183:1173-1183.
7. Traversari, C., P. van der Bruggen, I.F. Luescher, C. Lurquin, P. Chomez, A. Van Pel, E. De Plaen, A. Amar-Costesec, and T. Boon. 1992. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176:1453-1457.
8. van der Bruggen, P., J. Bastin, T. Gajewski, P.G. Coulie, P. Boël, C. De Smet, C. Traversari, A. Townsend, and T. Boon. 1994. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24:3038-3043.
9. Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J.J. Gaforio, E. De Plaen, B. Lethé, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179: 921-930.
10. Cox, A.L., J. Skipper, Y. Chen, R.A. Henderson, T.L. Darrow, J. Shabanowitz, V.H. Engelhard, D.F. Hunt, and C.L. Slingluff, Jr. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science. 264:716-719.
11. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P. F. Robbins, L. Rivoltini, J. R. Yannelli, E. Appella, and S. A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347-352.
12. Kawakami, Y., S. Eliyahu, C. Jennings, K. Sakaguchi, X. Kang, S. Southwood, P.F. Robbins, A. Sette, E. Appella, and S.A. Rosenberg. 1995. Recognition of multiple epitopes in the human melanoma antigen gp 100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154:3961-3968.
13. Kang, X., Y. Kawakami, M. El-Gamil, R. Wang, K. Sakaguchi, J.R. Yannelli, E. Appella, S.A. Rosenberg, and P.F. Robbins. 1995. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J. Immunol. 155:1343-1348.
14. Wang, R.-F., E. Appella, Y. Kawakami, X. Kang, and S.A. Rosenberg. 1996. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. Exp. Med. 184:2207-2216.
15. + cytotoxic T lymphocytes. J. Exp. Med. 181:363-368.
16. Marchand, M., P. Weynants, E. Rankin, F. Arienti, F. Belli, G. Parmiani, N. Cascinelli, A. Bourlond, R. Vanwijck, Y. Humblet, et al. 1995. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer. 63:883-885.
17. Mandruzzato, A., F. Brasseur, G. Andry, T. Boon, and P. van der Bruggen. 1997. A CASP-8 mutation recognized by cytotoxic T lymphocytes on a human head and neck carcinoma. J. Exp. Med. 186:785-793.
18. Nakao, M., H. Yamana, Y. Imai, Y. Toh, U. Toh, A. Kimura, S. Yanoma, T. Kakegawa, and K. Itoh. 1995. HLA A2601-restricted CTLs recognize a peptide antigen expression on squamous cell carcinoma. Cancer Res. 55:4248-4252.
19. Shichijo, S., A. Hayashi, S. Takamori, R. Tsunosue, T. Hoshino, M. Sakata, T. Kuramoto, K. Oizumi, and K. Itoh. 1995. Detection of MAGE-4 protein in lung cancer. Int. J. Cancer. 54:158-165.
20. Kim, T., A.C. von Eschenbach, M.D. Filaccio, K. Hayakawa, D.R. Parkinson, C.M. Balch, and K. Itoh. 1990. Clonal analysis of lymphocytes from tumor, peripheral blood, and nontumorous kidney in primary renal cell carcinoma. Cancer Res. 50:5263-5268.
21. Kozak, M. 1986. Bifunctional messenger RNAs in eukaryotes. Cell. 47:481-483.
22. Kozak, M. 1989. The scanning model for translation: an update. J. Cell Biol. 108:229-241.
23. Larsen, B., J. Peden, S. Matsufuji, T. Matsufuji, K. Brady, R. Maldonado, N.M. Wills, O. Fayet, J.F. Atkins, and R.F. Gesteland. 1995. Upstream stimulators for recoding. Biochem. Cell Biol. 73:1123-1129.
24. Sachs, A.B., P. Sarnow, and M.W. Hentze. 1997. Stating at the beginning, middle, and end: translation initiation in eukaryotes. Cell. 89:831-838.
25. Nomoto, A., N. Kitamura, F. Golini, and E. Wimmer. 1977. The 5′-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked VPg. Proc. Natl. Acad. Sci. USA. 74:5345-5349.
26. Pelletier, J., and N. Sonenberg. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature. 334:320-325.
27. Pilipenko, E.V., A.P. Gmyl, S.V. Maslova, Y.V. Svitkin, A.N. Sinyakov, and V.I. Agol. 1992. Prokaryotic-like cis elements in the cap-independent internal initiation of translation on picornavirus RNA. Cell. 68:119-131.
28. Descombes, P., and U. Schibler. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell. 67:569-579.
29. Ossipow, V., P. Descombes, and U. Schibler. 1993. CCAAT/ enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. USA. 90:8219-8223.
30. Wang, R.-F., M.R. Parkhurst, Y. Kawakami, P.F. Robbins, and S.A. Rosenberg. 1996. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J. Exp. Med. 183:1131-1140.
31. Curran, T., and B.R. Franza, Jr. 1988. Fos and Jun: the AP-1 connection. Cell. 55:395-397.
32. Ron, D., and J.F. Habener. 1990. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6: 439-453.
33. Arnett, K.L., and P. Parham. 1995. HLA class I nucleotide sequences. Tissue Antigens. 45:217-257.
34. Goulder, P., C. Conlon, K. McIntyre, and A. McMichael. 1994. Identification of a novel human leukocyte antigen A26-restricted epitope in a conserved region of Gag. AIDS (Phila). 10:1441-1443.
35. Tanigaki, N., D. Fruci, A. Chersi, G. Falasca, R. Tosi, and R.H. Butler. 1994. HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products. Hum. Immunol. 39:155-162.
36. Parkhurst, M.R., M.L. Salgaller, S. Southwoog, P.F. Robbins, A. Sette, S.A. Rosenberg, and Y. Kawakami. 1996. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A0201-binding residues. J. Immunol. 157:2539-2548.
37. Imanishi, T., T. Akaza, A. Kimura, K. Tokunaga, and T. Gojobon. 1992. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In HLA 1991. Vol. 1. K. Tsuji, M. Aizawa, and T. Sasazuki, editors. Oxford, Scientific Publications, Oxford. 1065-1220.
38. Date, Y., A. Kimura, H. Kato, and T. Sasazuki. 1996. DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens. 47:93-101.